ADP
65
-3
APH
65
-3
AMT
37
3
WEC
53
5
K
51
-3
RL
69
-4
SYF
86
-6
WYNN
36
-5
BDX
56
10
XEL
67
2
D
40
2
REGN
38
-2
DE
42
3
HAL
48
-3
DTE
43
5
PG
50
2
NWSA
62
-7
EL
15
-3
CFG
74
2
PLD
45
-5
ADP
65
-3
APH
65
-3
AMT
37
3
WEC
53
5
K
51
-3
RL
69
-4
SYF
86
-6
WYNN
36
-5
BDX
56
10
XEL
67
2
D
40
2
REGN
38
-2
DE
42
3
HAL
48
-3
DTE
43
5
PG
50
2
NWSA
62
-7
EL
15
-3
CFG
74
2
PLD
45
-5
Financhill
Back

Poseida Therapeutics Quote, Financials, Valuation and Earnings

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.
Sell
45

PSTX
Poseida Therapeutics

Last Price:
2.75
Seasonality Move:
20.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.

Poseida Therapeutics Price Quote

$2.75
-0.01 (-14.33%)
(Updated: November 16, 2024 at 5:34 AM ET)

Poseida Therapeutics Key Stats

Sell
45
Poseida Therapeutics (PSTX) is a Sell
Day range:
$2.73 - $3.28
52-week range:
$1.87 - $4.27
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.06
P/B ratio:
3.59%
Volume:
699.9K
Avg. volume:
517.8K
1-year change:
24.89%
Market cap:
$312.9M
Revenue:
$64.7M
EPS:
$-0.62

How Much Does Poseida Therapeutics Make?

Is Poseida Therapeutics Growing As A Company?

  • What Is Poseida Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 6.67%
  • What Is Poseida Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Poseida Therapeutics Stock Price Performance

What Is Poseida Therapeutics 52-Week High & Low?

Poseida Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Poseida Therapeutics?

Is Poseida Therapeutics Cash Flow Positive?

  • What Is PSTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$15M
  • What Is Poseida Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $699K
  • What Is Poseida Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $38.2M

Poseida Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    PSTX return on invested capital is -40.32%
  • What Is Poseida Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -21.23%
  • What Is PSTX Return On Equity?
    ROE is a measure of profitability and is -66.05%

Poseida Therapeutics Earnings Date & Stock Price

Poseida Therapeutics Competitors

Poseida Therapeutics Dividend Yield

Poseida Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 149.61%
Revenue: 667.19% 341.53%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.00
Upside from Last Price: 407.25%

Major Shareholders

  • How many PSTX shares are owned by institutional investors?
    102.9M PSTX shares are owned by institutional investors
  • How many PSTX shares are owned by insiders?
    3.7M PSTX shares are owned by insiders